Hybrid Membrane-Derived Nanoparticles for Isoliquiritin Enhanced Glioma Therapy

• Main Authors: Wenwan Shi (Author), Xia Cao (Author), Qi Liu (Author), Qin Zhu (Author), Kai Liu (Author), Tianwen Deng (Author), Qingtong Yu (Author), Wenwen Deng (Author), Jiangnan Yu (Author), Qilong Wang (Author), Ximing Xu (Author)
• Format: Book
• Published: MDPI AG, 2022-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Due to the obstruction and heterogeneity of the blood-brain barrier, the clinical treatment of glioma has been extremely difficult. Isoliquiritigenin (ISL) exhibits antitumor effects, but its low solubility and bioavailability limit its application potential. Herein, we established a nanoscale hybri...